Novacept NovaSure To Compete With Ethicon In U.S. Menorrhagia Market

The relatively short procedure time required for endometrial ablation with Novacept's NovaSure device will prove a key advantage over other menorrhagia treatment systems, the firm maintains.

More from Archive

More from Medtech Insight